Ekso Bionics® is a leading developer of exoskeleton solutions that amplify human potential by supporting or enhancing strength, endurance, and mobility across medical and industrial applications.
EksoNR is the latest-generation device of the most clinically used robotic exoskeleton on the market. It was previously cleared by the FDA for stroke...the indications for use now expanded to include MS, the EksoNR has the potential to assist significantly more patients and improve patient mobility. We are excited...globally. Every five minutes someone is diagnosed with MS. In addition to its FDA clearances, EksoNR is CE-marked and available in Europe. Used...rehabilitation, we are committed to maximizing patient access to our technology,” said Steven Sherman, Chairman and Chief Executive Officer of Ekso Bionics. “With...by more than 400 rehabilitation centers globally, Ekso devices have helped patients take nearly 200 million steps, while supporting patients’ hopes of mobility
To use the full function of this web site, JavaScript needs to be enabled in your browser.
This is how you enable JavaScript in your browser settings: Read instruction
